Controlled Substances (Controlled Drugs, Precursors and Plants) Regulations 2000 (SA)
South Australia
under the
These regulations may be cited as the
Controlled Substances (Controlled Drugs, Precursors and Plants) Regulations 2000 .
In these regulations, unless the contrary intention appears—
Act means theControlled Substances Act 1984 ;
DDU means discrete dosage unit;
hemp seed oil means the oil obtained by cold expression from the seeds of cannabis.
(1) For the purposes of paragraph (b) of the definition of
general drug detection in section 4(1) of the Act, an electronic drug detection system may only be used in a manner consistent with this regulation.(2) An electronic drug detection system may only be used in relation to a person in accordance with the following:
(a) by taking samples of particulate matter from—
(i) the outside of the person's clothing; and
(ii) the person's hands,
for the purpose of analysis to detect the presence of a controlled drug, controlled precursor or controlled plant;
(b) the person cannot be required to remove, undo or rearrange any clothing for the purpose of taking such samples from the person's clothing;
(c) in taking such samples from the person's clothing, care must be taken to avoid disturbing the person's clothing.
(3) An electronic drug detection system may only be used in relation to property (other than a vehicle) by taking samples of particulate matter from the outside of the property for the purpose of analysis to detect the presence of a controlled drug, controlled precursor or controlled plant.
(4) An electronic drug detection system may only be used in relation to a vehicle in accordance with the following:
(a) by taking samples of particulate matter from both the exterior and interior of the vehicle (but not from the inside of any internal storage compartment) for the purpose of analysis to detect the presence of a controlled drug, controlled precursor or controlled plant;
(b) articles must not be removed from the vehicle for the purpose of taking such samples.
(5) For the purposes of this regulation, samples of particulate matter may be taken by swabbing, wiping or otherwise touching a surface to obtain a sample of particles from that surface.
(6) In this regulation—
internal storage compartment , in relation to a vehicle, means a glove box, drawer, cupboard, pocket or other similar compartment within the vehicle that is designed by the manufacturer—
(a) for the storage of items in the vehicle; and
(b) to be capable of being sealed or closed,
but does not include general internal space within a vehicle such as the rear of a station wagon, panel van or van, the boot of a car or any other similar space;
vehicle includes a caravan, trailer or anything else being towed by the vehicle.
(1) In accordance with section 12(4) of the Act, the following substances are declared to be controlled drugs:
(a) the natural or synthetic form of a substance listed in Schedule 1;
(b) any salt, derivative or isomer of the natural or synthetic form of a substance listed in Schedule 1 and any salt of such derivative or isomer;
(c) any analogue of the natural or synthetic form of a substance listed in Schedule 1 (being an analogue having a substantially similar chemical structure to the substance, but differing in elemental composition due to the addition, deletion or replacement of any substituent element or group);
(d) any homologue of the natural or synthetic form of a substance listed in Schedule 1 (being a homologue differing from the substance by 1 or more carbon containing groups (including methylene groups) in the chemical structure);
(e) any of the substances referred to in a preceding paragraph whether existing alone or in a preparation, admixture, solution or natural substance.
(2) In accordance with section 12(4a) of the Act, the following substances are declared to be controlled precursors:
(a) the natural or synthetic form of a substance listed in Schedule 2;
(b) any salt, isomer, ester, ether, ketal, acetal, acetate, hydroxide, oxime, amide, imine, acid chloride, nitrile, anhydride, halogen substituent, epoxide, diol or any analogue or derivative of the natural or synthetic form of a substance listed in Schedule 2;
(c) any of the substances referred to in a preceding paragraph whether existing alone or in a preparation, admixture, solution or natural substance.
(3) In accordance with section 12(4b) of the Act, the following plants are declared to be controlled plants:
(a) a growing plant listed in Schedule 3 Part 1;
(b) a cutting taken from a plant listed in Schedule 3 Part 1 (provided that the cutting has been planted or otherwise placed in a growing medium).
(1) For the purposes of the definition of
large commercial quantity in section 4(1) of the Act, the quantity of a particular controlled drug or controlled plant prescribed as alarge commercial quantity of the drug or plant in its pure form is—(a) in the case of a controlled drug—the amount (if any) listed in the column headed "Large commercial (pure)" of the tables in Part 1 or 2 of Schedule 1 opposite the entry listing the controlled drug; or
(c) in the case of a controlled plant—the amount (if any) listed in the column headed "Large commercial" of the tables in Part 1 or 2 of Schedule 3 opposite the entry listing the controlled plant.
(2) For the purposes of the definition of
large commercial quantity in section 4(1) of the Act, the quantity of a mixture containing a particular controlled drug or controlled precursor prescribed as alarge commercial quantity for any mixture containing the drug or precursor is—(a) in the case of a controlled drug—the amount (if any) listed in the column headed "Large commercial (mixed)" of the tables in Part 1 or 2 of Schedule 1 opposite the entry listing the controlled drug; or
(b) in the case of a controlled precursor—the amount (if any) listed in the column headed "Large commercial (mixed)" of the table in Schedule 2 opposite the entry listing the controlled precursor.
(2a) For the purposes of the definition of
large commercial quantity in section 4(1) of the Act, the number of DDUs of a mixture containing a particular controlled drug prescribed as alarge commercial quantity for any mixture containing the controlled drug is the number of DDUs (if any) listed in the column headed "Large commercial (mixed)" of the tables in Part 1 or 2 of Schedule 1 opposite the entry listing the controlled drug.(3) For the purposes of the definition of
commercial quantity in section 4(1) of the Act, the quantity of a particular controlled drug or controlled plant prescribed as acommercial quantity of the drug or plant in its pure form is—(a) in the case of a controlled drug—the amount (if any) listed in the column headed "Commercial (pure)" of the tables in Part 1 or 2 of Schedule 1 opposite the entry listing the controlled drug; or
(c) in the case of a controlled plant—the amount (if any) listed in the column headed "Commercial" of the tables in Part 1 or 2 of Schedule 3 opposite the entry listing the controlled plant.
(4) For the purposes of the definition of
commercial quantity in section 4(1) of the Act, the quantity of a mixture containing a particular controlled drug or controlled precursor prescribed as acommercial quantity for any mixture containing the drug or precursor is—(a) in the case of a controlled drug—the amount (if any) listed in the column headed "Commercial (mixed)" of the tables in Part 1 or 2 of Schedule 1 opposite the entry listing the controlled drug; or
(b) in the case of a controlled precursor—the amount (if any) listed in the column headed "Commercial (mixed)" of the table in Schedule 2 opposite the entry listing the controlled precursor.
(4a) For the purposes of the definition of
commercial quantity in section 4(1) of the Act, the number of DDUs of a mixture containing a particular controlled drug prescribed as acommercial quantity for any mixture containing the controlled drug is the number of DDUs (if any) listed in the column headed "Commercial (mixed)" of the tables in Part 1 or 2 of Schedule 1 opposite the entry listing the controlled drug.(5) For the purposes of the definition of
trafficable quantity in section 4(1) of the Act, the quantity of a particular controlled plant prescribed as atrafficable quantity of the controlled plant in its pure form is the amount (if any) listed in the column headed "Trafficable" of the tables in Part 1 or 2 of Schedule 3 opposite the entry listing the controlled plant.(6) For the purposes of the definition of
trafficable quantity in section 4(1) of the Act, the quantity of a mixture containing a particular controlled drug prescribed as atrafficable quantity for any mixture containing the controlled drug is the amount (if any) listed in the column headed "Trafficable (mixed)" of the tables in Part 1 or 2 of Schedule 1 opposite the entry listing the controlled drug.(7) For the purposes of the definition of
trafficable quantity in section 4(1) of the Act, the number of DDUs of a mixture containing a particular controlled drug prescribed as atrafficable quantity for any mixture containing the controlled drug is the number of DDUs (if any) listed in the column headed "Trafficable (mixed)" of the tables in Part 1 or 2 of Schedule 1 opposite the entry listing the controlled drug.
For the purposes of section 33K of the Act, the prescribed number of cannabis plants is 5.
Section 33L(1)(c) of the Act does not apply to a person having in his or her possession a syringe or needle for use in connection with the administration of a controlled drug.
(1) For the purposes of section 33LA of the Act—
(a) the following equipment (being equipment that is, or may at some stage have been, capable of being used for hydroponic cannabis cultivation) is prescribed:
(i) metal halide lights, high pressure sodium lights and mercury vapour lights of 400 watts or greater;
(ii) ballast boxes;
(iii) devices (including control gear, lamp mounts and reflectors) designed to amplify light or heat;
(iv) carbon filters designed to filter air within a room, or from 1 area of a building to another or to outside;
(v) cannabis bud or head strippers;
(vi) units designed to contain plants and rotate around a light source so that the plants grow hydroponically while being exposed to a consistent degree of light or heat or both; and
(b) the following equipment (being equipment that is, or may at some stage have been, capable of being used in the manufacture of controlled drugs) is prescribed:
(i) condensers;
(ii) distillation heads;
(iii) heating mantles;
(iv) rotary evaporators;
(v) heater‑stirrers;
(vi) mechanical‑stirrers;
(vii) pressure reaction vessels;
(viii) separatory funnels;
(ix) buchner flasks;
(x) in‑line membrane filters;
(xi) reaction vessels;
(xii) splash heads;
(xiii) tube furnaces;
(xiv) manual or mechanical tablet presses, including parts for such an item;
(xv) manual or mechanical encapsulators, including parts for such an item;
(xvi) an item modified to perform the function of a condenser, distillation head, splash head, pressure reaction vessel or tube furnace; and
(c) a device comprising a hydraulic compression system and a die that is, or may at some stage have been, capable of being used to compress a powdered substance into blocks is prescribed.
(2) Equipment described in subregulation (1) is prescribed for the purposes of section 33LA of the Act regardless of whether the equipment is in working order or has been, or is being, modified in any way.
The quantity of a mixture containing a particular controlled precursor prescribed for the purposes of section 33LB for any mixture containing the controlled precursor is the amount (if any) listed in the column headed "Commercial (mixed)" of the table in Schedule 2 opposite the entry listing the controlled precursor.
(1) For the purposes of sections 33LB(2)(b) and 33J(2)(b) of the Act—
(a) the following equipment (being equipment that is, or may at some stage have been, capable of being used in the manufacture of controlled drugs) is prescribed:
(i) condensers;
(ii) distillation heads;
(iii) heating mantles;
(iv) rotary evaporators;
(v) heater‑stirrers;
(vi) mechanical‑stirrers;
(vii) pressure reaction vessels;
(viii) separatory funnels;
(ix) buchner flasks;
(x) in‑line membrane filters;
(xi) reaction vessels;
(xii) splash heads;
(xiii) tube furnaces;
(xiv) manual or mechanical tablet presses, including parts for such an item;
(xv) manual or mechanical encapsulators, including parts for such an item;
(xvi) an item modified to perform the function of a condenser, distillation head, splash head, pressure reaction vessel or tube furnace; and
(b) a device comprising a hydraulic compression system and a die that is, or may at some stage have been, capable of being used to compress a powdered substance into blocks is prescribed.
(2) Equipment described in subregulation (1) is prescribed for the purposes of sections 33LB and 33J of the Act regardless of whether the equipment is in working order or has been, or is being, modified in any way.
(1) For the purposes of section 33S, a circumstance consisting of the sale or supply of syringes or needles, or the giving of advice or instruction on the safe use of syringes or needles, by—
(a) a medical practitioner; or
(b) a pharmacist; or
(c) a person acting in the course of a health risk minimisation program,
is prescribed.
(2) In this regulation—
health risk minimisation program means a program—
(a) designed to facilitate—
(i) the supply to intravenous drug users of sterile syringes and sterile needles, and any associated equipment, to prevent the spread of infectious diseases and minimise health risks associated with intravenous drug use; and
(ii) the giving out of information concerning safe practices in the use of syringes and needles to prevent the spread of infectious diseases; and
(b) declared by the Minister, by notice in writing given personally or by post to the person responsible for conducting the program, to be a health risk minimisation program for the purposes of this regulation.
(3) The Minister may, by subsequent notice in writing given personally or by post to the person responsible for conducting the program, vary or revoke the declaration.
For the purposes of section 44(1)(da) of the Act, a prescribed place is any place where members of the public are gathered for an entertainment or an event or activity of any kind, whether admission is open, procured by the payment of money or restricted to members of a club or a class of persons with some other qualification or characteristic.
In accordance with section 45A(3) of the Act, the fees fixed for the expiation of simple cannabis offences are set out in Schedule 5.
(1) For the purposes of paragraph (a) of the definition of
simple cannabis offence in section 45A(8) of the Act, the prescribed number of cannabis plants is 1.(2) For the purposes of paragraph (b) of the definition of
simple cannabis offence in section 45A(8) of the Act, the following quantities of cannabis, cannabis resin and cannabis oil are prescribed:
(a) in the case of cannabis—100 grams;
(b) in the case of cannabis resin—20 grams;
(c) in the case of cannabis oil—0 millilitres.
(3) For the purposes of paragraph (c) of the definition of
simple cannabis offence in section 45A(8) of the Act, a motor vehicle, train, tram or any other vehicle is, while in a public place, prescribed.
(1) For the purposes of section 52E(6) of the Act, where samples of cannabis are to be taken, they must be taken as follows:
(a) in the case of a crop of growing or newly harvested plants consisting of—
(i) 10 or fewer plants—at least one sample must be taken;
(ii) 11 to 20 plants—at least 5 samples must be taken;
(iii) 21 to 100 plants—at least 10 samples must be taken;
(iv) more than 100 plants—at least 20 samples must be taken;
(b) in the case of dried and packaged cannabis, a sample of at least 10 grams must be taken from each package.
(2) Each sample must be separately packaged and identified.
(3) For the purposes of this regulation—
samples , in relation to plants, means—
(a) if the plants are immature (that is to say, they do not have any fully developed leaves) the plants themselves;
(b) if the plants are mature, a fully developed leaf or flowerhead (taken from separate plants if more than one sample is required).
For the purposes of section 53(3) of the Act—
(a) the prescribed manner of initiating an analysis is by notice in writing, addressed to the analyst, describing the substance to be analysed and signed by the person initiating the analysis; and
(b) the prescribed fee for analysis is $207 per substance.
For the purposes of section 53(4) of the Act, the form set out in Schedule 4 is the prescribed form for the certificate of analysis.
Part 1—Controlled drugs other than drugs of dependence
A reference in the table below to schedule 2, 3 or 4 is a reference to the corresponding schedule of the Uniform Poisons Standard as incorporated into the
Controlled Substances (Poisons) Regulations 2011 .
Acetorphine | 2kg | 0.5kg | 3g | ||
Acetyl‑alpha‑methylfentanyl | 0.005kg | 0.00125kg | 0.0075g | ||
Allylprodine | 1kg | 0.25kg | 1.5g | ||
Alpha‑methylfentanyl | 0.005kg | 0.00125kg | 0.0075g | ||
Alpha‑methylthiofentanyl | 0.005kg | 0.00125kg | 0.0075g | ||
Alpha‑methyltryptamine (α‑MT) | 1kg or 100 DDUs | 0.2kg or 20 DDUs | 2g or 10 DDUs | ||
5-(2-aminopropyl)benzofuran (5-APB) | 1kg | 0.5kg | 2g | ||
6-(2-aminopropyl)benzofuran (6‑APB) | 1kg | 0.5kg | 2g | ||
5-(2‑aminopropyl)indan | 1kg | 0.25kg | 3g | ||
3-(2‑aminopropyl)indole (AMT) | 0.2kg | 0.05kg | 5g | ||
arylcyclohexylamines (not otherwise listed in this Schedule) | 2kg or 100 DDUs | 0.5kg or 20 DDUs | 6g or 10 DDUs | ||
Benzethidine | 10kg | 2.5kg | 15g | ||
Benzoylecgonine | 1kg | 0.25kg | 3g | ||
Benzoylindoles (not otherwise listed in this Schedule) | 12.5kg or 100 DDUs | 2.5kg or 20 DDUs | 250g or 10 DDUs | ||
Benzylpiperazines (not otherwise listed in this Schedule) | 1kg | 0.25kg | 3g | ||
1‑Benzylpiperazine (BZP) | 1kg | 0.25kg | 3g | ||
Beta‑hydroxyfentanyl | 0.005kg | 0.00125kg | 0.0075g | ||
Beta‑hydroxy‑3‑methylfentanyl | 0.005kg | 0.00125kg | 0.0075g | ||
4‑Bromo‑2,5-dimethoxyamphetamine | 0.2kg | 0.05kg | 5g | ||
2-(4-bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl] ethanamine (25B-NBOMe) | 0.015kg or 100 DDUs | 0.005kg or 20 DDUs | 0.015g or 10 DDUs | ||
1‑(8‑Bromobenzo[1,2‑b:4,5‑b] difuran‑4‑yl)‑2‑aminopropane (Bromo‑Dragonfly) | 100 DDUs | 20 DDUs | 10 DDUs | ||
Bufotenine | 2kg | 0.5kg | 2g | ||
1,4‑Butanediol | 2kg | 0.5kg | 50g | ||
1-butyl-3-(1-naphthoyl)indole (JWH-073) | 12.5kg or 100 DDUs | 2.5kg or 20 DDUs | 250g or 10 DDUs | ||
Cannabis - oil (other than hemp seed oil) | 2kg | 10kg | 1kg | 2kg | 25g |
Cannabis - resin | 2kg | 10kg | 1kg | 2kg | 25g |
Cannabis - plant material including flowering and fruiting tops, leaves, seeds or stalks but not including oil or resin | 2kg | 12.5kg | 1kg | 2.5kg | 250g |
Cathinones (not otherwise listed in this Schedule) | 0.75kg | 1kg | 0.1kg | 0.5kg | 2g |
4‑Chloro‑2,5‑ dimethoxyamphetamine | 0.2kg or 100 DDUs | 0.05kg or 20 DDUs | 5g or 10 DDUs | ||
2-(4-chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl] ethanamine (25C-NBOMe) |
0.015kg or 100 DDUs | 0.005kg or 20 DDUs | 0.015g or 10 DDUs | |||
1‑(3‑Chlorophenyl)piperazine | 1kg | 0.25kg | 3g | ||
Clonitazene | 5kg | 1.25kg | 7.5g | ||
Codoxime | 10kg | 2.5kg | 15g | ||
4‑Cyano‑2‑dimethylamino‑4,4‑ diphenylbutane (methadone intermediate) | 2kg | 0.5kg | 3g | ||
1-cyclohexylethyl-3-(2-methoxyphenylacetyl)indole (RCS-8) | 12.5kg or 100 DDUs | 2.5kg or 20 DDUs | 250g or 10 DDUs | ||
Cyclohexylphenols (not otherwise listed in this Schedule) | 12.5kg or 100 DDUs | 2.5kg or 20 DDUs | 250g or 10 DDUs | ||
Desomorphine | 2kg | 0.5kg | 3g | ||
N,N‑Di‑(N)‑propyltryptamine (DPT) | 1kg or 100 DDUs | 0.2kg or 20 DDUs | 2g or 10 DDUs | ||
Diampromide | 5kg | 1.25kg | 7.5g | ||
Dibenzopyrans (not otherwise listed in this Schedule) | 12.5kg or 100 DDUs | 2.5kg or 20 DDUs | 250g or 10 DDUs | ||
Diethylthiambutene | 5kg | 1.25kg | 7.5g | ||
N,N-Diethyltryptamine | 1kg or 100 DDUs | 0.2kg or 20 DDUs | 2g or 10 DDUs | ||
Dihydrohydroxymorphine | 10kg | 2.5kg | 250g | ||
Dimenoxadol | 10kg | 2.5kg | 125g | ||
Dimepheptanol | 10kg | 2.5kg | 125g | ||
N,N‑Dimethyl‑5‑methoxy tryptamine (5‑MeO‑DMT) | 1kg or 100 DDUs | 0.2kg or 20 DDUs | 2g or 10 DDUs | ||
N,N-Dimethylamphetamine | 1kg | 0.5kg | 2g | ||
3-(1,2-Dimethylheptyl)‑1‑hydroxy-7,8,9,10-tetrahydro‑6, 6,9‑trimethyl‑6h‑dibenzo (b,d) pyran (DMHP) | 2kg | 0.5kg | 3g | ||
5-(1,1-dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (CP-47,497) | 12.5kg or 100 DDUs | 2.5kg or 20 DDUs | 250g or 10 DDUs | ||
5-(1,1-dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (cannabicyclohexanol) | 12.5kg or 100 DDUs | 2.5kg or 20 DDUs | 250g or 10 DDUs | ||
Dimethylthiambutene | 5kg | 1.25kg | 7.5g | ||
N,N‑Dimethyltryptamine | 2kg or 100 DDUs | 0.5kg or 20 DDUs | 3g or 10 DDUs | ||
2,5‑Dimethoxy‑4‑ bromophenethylamine | 1kg | 0.5kg | 2g | ||
2,5‑Dimethoxy‑4‑ chlorophenethylamine | 1kg | 0.5kg | 2g | ||
2,5-Dimethoxy‑4-ethylthiophenethylamine | 1kg | 0.5kg | 2g | ||
2,5-Dimethoxy‑4-iodophenethylamine | 1kg | 0.5kg | 2g | ||
2,5‑Dimethoxy‑4‑ methylphenethylamine | 1kg | 0.5kg | 2g | ||
2,5-Dimethoxy‑4‑(N)‑ propylthiophenethylamine | 1kg or 100 DDUs | 0.5kg or 20 DDUs | 2g or 10 DDUs | ||
Dioxaphetylbutyrate | 2kg | 0.5kg | 3g | ||
Ecgonine | 1kg | 0.25kg | 3g | ||
(RS)-2-ethylamino-1-(4-methylphenyl)propan-1-one (4-methylethcathinone or 4-MEC) | 1kg | 0.5kg | 2g | ||
4,5-Ethylenedioxy-3-methoxyamphetamine | 1kg | 0.5kg | 2g | ||
Ethylmethylthiambutene | 5kg | 1.25kg | 7.5g | ||
4-Ethylnaphthalen-1-yl-(1-pentylindol-3-yl)methanone (JWH-210) | 12.5kg or 100 DDUs | 2.5kg or 20 DDUs | 250g or 10 DDUs | ||
N‑Ethyl-1-phenylcyclohexylamine | 0.4kg | 0.1kg | 0.0075g | ||
Eticyclidine (PCE) | 0.004kg | 0.001kg | 0.0075g | ||
Etonitazene | 5kg | 1.25kg | 7.5g | ||
Etorphine | 5kg | 1.25kg | 7.5g | ||
Etoxeridine | 5kg | 1.25kg | 7.5g | ||
Fenethylline | 2kg | 0.5kg | 3g | ||
(1-(5-fluoropentyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl) methanone (XLR-11) | 12.5kg or 100 DDUs | 2.5kg or 20 DDUs | 250g or 10 DDUs | ||
1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole (AM-694) | 12.5kg or 100 DDUs | 2.5kg or 20 DDUs | 250g or 10 DDUs | ||
1-(5-fluoropentyl)-3-(1-naphthoyl)indole (AM-2201) | 12.5kg or 100 DDUs | 2.5kg or 20 DDUs | 250g or 10 DDUs | ||
4‑Fluoro‑N‑methylamphetamine | 1kg | 0.5kg | 2g | ||
Furethidine | 1kg | 0.25kg | 1.5g | ||
Harmaline | 5kg | 1.25kg | 20g | ||
Harmine | 5kg | 1.25kg | 20g | ||
Harmines (not otherwise listed in this Schedule) | 5kg | 1.25kg | 20g | ||
Heroin (diacetylmorphine/diamorphine) | 0.75kg | 1kg | 0.1kg | 0.2kg | 2g |
3‑Hexyl‑1‑hydroxy‑7,8,9,10-tetrahydro-6,6,9- trimethyl‑6H‑dibenzo (b,d)pyran | 4kg | 25kg | 1kg | 10kg | 25g |
1-hexyl-3-(1-naphthoyl)indole (JWH-019) | 12.5kg or 100 DDUs | 2.5kg or 20 DDUs | 250g or 10 DDUs | ||
Hydroxyamphetamine | 5kg | 1.25kg | 6g | ||
4‑Hydroxybutanoic acid (GHB) | 2kg | 0.5kg | 50g | ||
4-Hydroxybutanoic acid lactone (GBL) | 2kg | 0.5kg | 50g | ||
Hydroxyfentanyl | 0.005kg | 0.00125kg | 0.0075g | ||
Hydroxy‑3‑methylfentanyl | 0.005kg | 0.00125kg | 0.0075g | ||
9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol (HU-210) | 12.5kg or 100 DDUs | 2.5kg or 20 DDUs | 250g or 10 DDUs | ||
Hydroxypethidine | 1kg | 0.25kg | 3g | ||
4‑Iodo‑2,5‑dimethoxy amphetamine | 0.2kg or 100 DDUs | 0.05kg or 20 DDUs | 5g or 10 DDUs | ||
2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl] ethanamine (25I-NBOMe) | 0.015kg or 100 DDUs | 0.005kg or 20 DDUs | 0.015g or 10 DDUs | ||
Isomethadone | 2kg | 0.5kg | 3g | ||
Ketobemidone | 2kg | 0.5kg | 3g | ||
Levomethorphan (excluding its stereoisomers) | 2kg | 0.5kg | 3g | ||
Lysergamide | 0.015kg | 0.005kg | 0.015g | ||
Lysergic acid | 0.015kg | 0.005kg | 0.015g | ||
Lysergic acid diethylamide (LSD) | 0.015kg or 100 DDUs | 0.005kg or 20 DDUs | 0.015g or 10 DDUs | ||
Mecloqualone | 5kg | 1.25kg | 15g | ||
Meprodine | 1kg | 0.25kg | 1.5g | ||
Mescaline (3,4,5-Trimethoxyphenethylamine) | 0.2kg | 0.05kg | 2g | ||
Metazocine | 7kg | 1.75kg | 125g | ||
Methadol | 5kg | 1.25kg | 15g | ||
Methaqualone | 5kg | 1.25kg | 7.5g | ||
Methcathinone | 0.75kg | 1kg | 0.1kg | 0.5kg | 2g |
Methcathinones (not otherwise listed in this Schedule) | 0.75kg | 1kg | 0.1kg | 0.5kg | 2g |
2-(3-Methoxyphenyl)-2-(ethylamino)cyclohexanone (methoxetamine) | 2kg or 100 DDUs | 0.5kg or 20 DDUs | 6g or 10 DDUs | ||
1‑(4‑Methoxyphenyl)piperazine | 1kg | 0.25kg | 3g | ||
4-methoxyphenyl(1butyl-1H-indol-3-yl)-methanone (RCS-4 (C4)) | 12.5kg or 100 DDUs | 2.5kg or 20 DDUs | 250g or 10 DDUs | ||
2-(4-Methoxyphenyl)-1-(1-pentyl-1H-indol-3-yl)-ethanone (JWH-201) | 12.5kg or 100 DDUs | 2.5kg or 20 DDUs | 250g or 10 DDUs | ||
2-(3-Methoxyphenyl)-1-(1-pentylindol-3-yl)ethanone (JWH-302) | 12.5kg or 100 DDUs | 2.5kg or 20 DDUs | 250g or 10 DDUs | ||
5‑Methoxy‑α‑methyltryptamine | 0.2kg or 100 DDUs | 0.05kg or 20 DDUs | 5g or 10 DDUs | ||
4‑Methyl‑2,5‑dimethoxy amphetamine | 1kg or 100 DDUs | 0.5kg or 20 DDUs | 2g or 10 DDUs | ||
N‑Methyl‑1‑(1,3‑benzodioxol‑ 5‑yl)‑2‑butanamine(MBDB) | 0.75kg | 0.1kg | 2g | ||
4‑methylaminorex | 1kg | 2.5kg | 0.25kg | 1.25kg | 6g |
Methyldesorphine | 2kg | 0.5kg | 3g | ||
3,4‑Methylenedioxyamphetamine (MDA) | 0.75kg | 1kg | 0.1kg | 0.5kg | 2g |
3,4-methylenedioxymethcathinone | 0.75kg | 1kg | 0.1kg | 0.5kg | 2g |
3,4‑Methylenedioxymethyl amphetamine (MDMA) | 0.75kg | 1kg | 0.1kg | 0.5kg | 2g |
3,4‑Methylenedioxy‑N‑ethyl amphetamine (MDEA) | 0.75kg | 1kg | 0.1kg | 0.5kg | 2g |
3,4-methylenedioxypyrovalerone (MDPV) | 0.75kg | 1kg | 0.1kg | 0.5kg | 2g |
3‑Methylfentanyl | 0.005kg | 0.00125kg | 0.0075g | ||
4‑Methylmethcathinone (Mephedrone) | 0.75kg | 1kg | 0.1kg | 0.5kg | 2g |
2‑Methyl‑3‑morpholino‑1,1-diphenylpropane carboxylic acid (Moramide intermediate) | 2kg | 0.5kg | 3g | ||
1‑Methyl‑4‑phenyl-4-propionoxypiperidine | 1kg | 0.25kg | 3g | ||
1-[(N-methylpiperidin-2-yl)methyl]-3-(2-iodobenzoyl)indole (AM-2233) | 12.5kg or 100 DDUs | 2.5kg or 20 DDUs | 250g or 10 DDUs | ||
(2-Methyl-1-propyl-1H-indol-3-yl)-1-naphthalenylmethanone (JWH-015) | 12.5kg or 100 DDUs | 2.5kg or 20 DDUs | 250g or 10 DDUs | ||
3‑Methylthiofentanyl | 0.005kg | 0.00125kg | 0.0075g | ||
Metopon | 2kg | 0.5kg | 3g | ||
Mitragynine | |||||
Monoacetylmorphine | 1.5kg | 0.6kg | 30g | ||
Morpheridine | 1.5kg | 0.6kg | 30g | ||
Morphinone | 1.5kg | 0.6kg | 30g | ||
1-[2-(4-morpholinyl)ethyl]-3-(1-naphthoyl)indole (JWH-200) | 12.5kg or 100 DDUs | 2.5kg or 20 DDUs | 250g or 10 DDUs | ||
Muscimol | 2kg | 0.5kg | 125g | ||
Myrophine | 20kg | 5kg | 30g | ||
Naphthoylindoles (not otherwise listed in this Schedule) | 12.5kg or 100 DDUs | 2.5kg or 20 DDUs | 250g or 10 DDUs | ||
Naphthoylpyrroles (not otherwise listed in this Schedule) | 12.5kg or 100 DDUs | 2.5kg or 20 DDUs | 250g or 10 DDUs | ||
Naphthylmethylindenes (not otherwise listed in this Schedule) | 12.5kg or 100 DDUs | 2.5kg or 20 DDUs | 250g or 10 DDUs | ||
Naphthylmethylindoles (not otherwise listed in this Schedule) | 12.5kg or 100 DDUs | 2.5kg or 20 DDUs | 250g or 10 DDUs | ||
Nicocodine | 4kg | 1kg | 500g | ||
Nicodicodine | 4kg | 1kg | 500g | ||
Nicomorphine | 4kg | 1kg | 500g | ||
Noracylmethadol | 2kg | 0.5kg | 3g | ||
Noracymethadol | 5kg | 1.25kg | 15g | ||
Norlevorphanol | 1kg | 0.25kg | 1.5g | ||
Normorphine | 20kg | 5kg | 30g | ||
Norpipanone | 10kg | 2.5kg | 15g | ||
Opium (except where it is a drug of dependence) | 4kg | 1kg | 30g | ||
Parafluorofentanyl | 0.005kg | 0.00125kg | 0.0075g | ||
Parahexyl | 0.2kg | 0.05kg | 5g | ||
Paramethoxyamphetamine (4‑Methoxyamphetamine or PMA) | 0.75kg | 1kg | 0.1kg | 0.5kg | 2g |
Paramethoxymethamphetamine (PMMA) | 0.75kg | 1kg | 0.1kg | 0.5kg | 2g |
1-pentyl-3-(1-naphthoyl)indole (JWH-018) | 12.5kg or 100 DDUs | 2.5kg or 20 DDUs | 250g or 10 DDUs | ||
1-pentyl-3-[1-(4-methoxynaphthoyl)indole (JWH-081) | 12.5kg or 100 DDUs | 2.5kg or 20 DDUs | 250g or 10 DDUs | ||
1-pentyl-3-(4-methyl-1-naphthoyl)indole (JWH-122) | 12.5kg or 100 DDUs | 2.5kg or 20 DDUs | 250g or 10 DDUs | ||
1-pentyl-3-(2-methoxyphenylacetyl)indole (JWH-250) | 12.5kg or 100 DDUs | 2.5kg or 20 DDUs | 250g or 10 DDUs | ||
1-pentyl-3-(4-chloro-1-naphthoyl)indole (JWH-398) | 12.5kg or 100 DDUs | 2.5kg or 20 DDUs | 250g or 10 DDUs | ||
1-Pentyl-3-(2-chlorophenylacetyl)indole (JWH-203) | 12.5kg or 100 DDUs | 2.5kg or 20 DDUs | 250g or 10 DDUs | ||
1-pentyl-3-[(4-methoxy)-benzoyl]indole (RCS-4) | 12.5kg or 100 DDUs | 2.5kg or 20 DDUs | 250g or 10 DDUs | ||
1-pentyl-N-tricyclo[3.3.1.13,7]dec-1-yl-1H-indazole-3-carboxamide (APINACA or AKB48) | 12.5kg or 100 DDUs | 2.5kg or 20 DDUs | 250g or 10 DDUs | ||
(1-Pentylindol-3-yl)naphthalen-1-ylmethane (JWH-175) | 12.5kg or 100 DDUs | 2.5kg or 20 DDUs | 250g or 10 DDUs | ||
(1-pentylindol-3-yl)-(2,2,3,3-tetramethylcyclopropyl) methanone (UR-144) | 12.5kg or 100 DDUs | 2.5kg or 20 DDUs | 250g or 10 DDUs | ||
Phenacylmorphan | 4kg | 1kg | 250g | ||
Phenadoxone | 10kg | 2.5kg | 15g | ||
Phenampromide | 10kg | 2.5kg | 15g | ||
Phenazocine | 1kg | 0.25kg | 1.5g | ||
Phencyclidine | 0.004kg | 0.001kg | 0.0075g | ||
N-Phenethyl-4-piperidone (NPP) | |||||
Phenethylamines (not otherwise listed in this Schedule) | 0.75kg | 1kg | 0.1kg | 0.5kg | 2g |
Phenomorphan | 5kg | 1.25kg | 7.5g | ||
Phenylacetylindoles (not otherwise listed in this Schedule) | 12.5kg or 100 DDUs | 2.5kg or 20 DDUs | 250g or 10 DDUs | ||
1‑(1-Phenylcyclohexyl) pyrrolidine | 0.004kg | 0.001kg | 0.0075g | ||
1‑Phenylethyl‑4-acetoxypiperidine | 0.004kg | 0.001kg | 0.0075g | ||
1‑(2‑Phenylethyl)‑4‑phenyl‑4-acetyloxypiperidine (PEPAP) | |||||
1-phenyl-2-(methylamino)pentan-1-one (pentedrone) | 1kg | 0.5kg | 2g | ||
(RS)-1-phenyl-2-(1-pyrrolidinyl)-1-pentanone (alpha-PVP or alpha-pyrrolidinovalerophenone) | 1kg | 0.5kg | 2g | ||
Piminodine | 10kg | 2.5kg | 15g | ||
Piperazines (not otherwise listed in this Schedule) | 1kg | 0.25kg | 3g | ||
Pravadoline (WIN 48098). | 12.5kg or 100 DDUs | 2.5kg or 20 DDUs | 250g or 10 DDUs | ||
Prodine | 1kg | 0.25kg | 1.5g | ||
Proheptazine | 1kg | 0.25kg | 1.5g | ||
Properidine | 28kg | 7kg | 40g | ||
Propoxyphene | 2kg | 0.5kg | 250g | ||
Psilocin (3-(2‑Dimethylaminoethyl)‑4-hydroxyindole) | 1kg | 0.25kg | 100g | ||
Psilocybin | 1kg | 0.25kg | 100g | ||
pyrovalerone (except when included in Schedule 4) | 0.75kg | 1kg | 0.1kg | 0.5kg | 2g |
pyrovalerones (not otherwise listed in this Schedule) | 0.75kg | 1kg | 0.1kg | 0.5kg | 2g |
Rolicyclidine (PHP or PCPY) | 0.004kg | 0.001kg | 0.0075g | ||
Salvinorin A | 0.2kg | 0.05kg | 5g | ||
Synthetic cannabinomimetics (not otherwise listed in this Schedule) | 12.5kg or 100 DDUs | 2.5kg or 20 DDUs | 250g or 10 DDUs | ||
Tenocyclodine (TCP) | 0.004kg | 0.001kg | 0.0075g | ||
Tetrahydrocannabinol (other than tetrahydrocannabinols— | 2kg | 12.5kg | 1kg | 2.5kg | 250g |
| |||||
| |||||
| |||||
Thiambuten | 5kg | 1.25kg | 7.5g | ||
1‑(1‑(2-Thienyl) cyclohexyl)piperidine | 0.004kg | 0.001kg | 0.0075g | ||
Thiofentanyl | 0.005kg | 0.00125kg | 0.0075g | ||
1-(thiophen-2-yl)-2-methylaminopropane (methiopropamine) | 1kg | 0.5kg | 2g | ||
1-(3-Trifluoromethylphenyl)piperazine (TFMPP) | 1kg | 0.25kg | 3g | ||
Trimeperidine | 10kg | 2.5kg | 15g | ||
Tryptamines (not otherwise listed in this Schedule) | 1kg or 100 DDUs | 0.2kg or 20 DDUs | 2g or 10 DDUs |
A reference in the table below to schedule 2, 3 or 4 is a reference to the corresponding schedule of the Uniform Poisons Standard as incorporated into the
Controlled Substances (Poisons) Regulations 2011 .
Acetyldihydrocodeine | 10 | 2.5 | 15 | ||
Acetylmethadol | 5 | 1.25 | 15 | ||
Acetylmorphines (except monoacetylmorphine and heroin (diacetylmorphine/diamorphine)) | |||||
Alfentanil | 2 | 0.5 | 3 | ||
Alphacetylmethadol | |||||
Alphaprodine | |||||
Amphetamine | 0.75 | 1 | 0.1 | 0.5 | 2 |
Amphetamines (not otherwise listed in this Schedule) | 1 | 0.5 | 2 | ||
Amylobarbitone (except when included in schedule 4) | 4 | 1 | 125 | ||
Anileridine | 10 | 2.5 | 15 | ||
Benzylmorphine (3‑benzylmorphine) | 5 | 1.25 | 7.5 | ||
Bezitramide | 5 | 1.25 | 7.5 | ||
Buprenorphine | 0.04 | 0.01 | 0.06 | ||
Butobarbitone | 4 | 1 | 125 | ||
Butorphanol | 2 | 0.5 | 3 | ||
Carfentanyl | 0.005 | 0.00125 | 0.0075 | ||
Cocaine | 0.75 | 1 | 0.1 | 0.2 | 2 |
Codeine (except when included in schedule 2, 3 or 4) | 2 | 0.5 | 125 | ||
Codeine‑N‑oxide | 10 | 2.5 | 15 | ||
4‑Cyano‑1‑methyl‑4-phenylpiperidine (pethidine intermediate A) | 1 | 0.25 | 3 | ||
Cyclobarbitone | 4 | 1 | 125 | ||
Dexamphetamine | 1kg | 0.5kg | 2g | ||
Dextromoramide | 1.5 | 0.6 | 30 | ||
Dextropropoxyphene (except when included in schedule 4) | |||||
Difenoxin (except when included in schedule 4) | 2 | 0.5 | 100 | ||
Dihydrocodeine (except when included in schedule 2, 3 or 4) | 10 | 2.5 | 250 | ||
Dihydromorphine | 10 | 2.5 | 250 | ||
Diphenoxylate (except when included in schedule 3 or 4) | 2 | 0.5 | 125 | ||
Dipipanone | 10 | 2.5 | 125 | ||
Dronabinol (delta-9- tetrahydrocannabinol) when prepared and packed for therapeutic use | 4kg | 25kg | 1kg | 10kg | 25g |
Drotebanol | 1 | 0.25 | 3 | ||
Ethylamphetamine | 1kg | 0.5kg | 2g | ||
Ethylmorphine (except when included in schedule 2 or 4) | 2 | 0.5 | 3 | ||
Fentanyl | 0.005 | 0.00125 | 0.0075 | ||
Flunitrazepam | 1.5 | 0.6 | 30 | ||
Hydrocodone | 2 | 0.5 | 3 | ||
Hydromorphinol | 2 | 0.5 | 3 | ||
Hydromorphone | 2 | 0.5 | 3 | ||
Ketamine | 2 | 0.5 | 6 | ||
Levomoramide | |||||
Levorphanol (excluding its stereoisomers) | 1 | 0.25 | 1.5 | ||
Methadone | 20 | 4 | 400 | ||
1‑Methyl‑4‑phenylpiperidine‑4‑ carboxylic acid (pethidine intermediate C) | 1 | 0.25 | 3 | ||
Methylamphetamine (Methamphetamine) | 0.75 | 1 | 0.1 | 0.5 | 2 |
Methyldihydromorphine | 2 | 0.5 | 3 | ||
Methylphenidate | 2 | 0.5 | 3 | ||
Morphine | 1 | 0.2 | 20 | ||
Morphine methobromide | 1.5 | 0.6 | 30 | ||
Morphine‑N‑oxide | 1.5 | 0.6 | 30 | ||
Nabilone | 0.4 | 0.1 | 0.6 | ||
Norcodeine | 4 | 1 | 500 | ||
Normethadone | 5 | 1.25 | 7.5 | ||
Opium (except the alkaloids noscapine when included in schedule 2 and papaverine when included in schedule 2 or 4) | 4 | 1 | 30 | ||
Oxycodone | 5 | 1.25 | 7.5 | ||
Oxymorphone | 2 | 0.5 | 3 | ||
Pentazocine | 5 | 1.25 | 125 | ||
Pentobarbitone (except when included in schedule 4) | 4 | 1 | 125 | ||
Pethidine | 1 | 0.2 | 20 | ||
Phendimetrazine | 10 | 2.5 | 15 | ||
Phenmetrazine | 5 | 1.25 | 7.5 | ||
Phenoperidine | 5 | 1.25 | 7.5 | ||
4‑Phenylpiperidine‑4‑carboxylic acid ethyl ester (pethidine intermediate B) | 1 | 0.25 | 3 | ||
Pholcodine (except when included in schedule 2 or 4) | 5 | 1.25 | 7.5 | ||
Piritramide | 1 | 0.25 | 1.5 | ||
Concentrate of poppy straw | |||||
Propiram | 2 | 0.5 | 3 | ||
Quinalbarbitone | 4 | 1 | 125 | ||
Racemoramide | |||||
Remifentanil | 0.2 | 0.05 | 0.3 | ||
Secbutobarbitone | 4 | 1 | 125 | ||
Sufentanil | 0.005 | 0.00125 | 0.0075 | ||
Thebacon | 2 | 0.5 | 3 | ||
Thebaine | 2 | 0.5 | 3 | ||
Tilidine | 1 | 0.25 | 3 |
Acetaldehyde | 2 kg | 0.5 kg |
Acetic anhydride | 4 L | 1 L |
N‑Acetylanthranilic acid | 20 kg | 5 kg |
Allylbenzene | 1 L | 0.25 L |
Allylpyrocatechol | 0.4 L | 0.1 L |
Alpha‑phenylacetoacetonitrile | 2 kg | 0.5 kg |
4‑Aminobutanoic acid | 6 kg | 1.5 kg |
Ammonia | 6 kg | 1.5 kg |
Ammonium formate | 2 kg | 0.5 kg |
Anethole | 0.4L | 0.1L |
Anthranilic acid | 20 kg | 5 kg |
Benzaldehyde | 2 L | 0.5 L |
1,3‑Benzodioxole | 1 L | 0.25 L |
Benzyl bromide | 2 L | 0.5 L |
Benzyl chloride | 2 L | 0.5 L |
Boron tribromide | 1 L | 0.25 L |
Bromobenzene | 2 L | 0.5 L |
5-Bromo‑1,3‑benzodioxole | 1 L | 0.25 L |
Bromosafrole | 0.2 L | 0.05 L |
1,4-Butanediol | 2kg | 0.5kg |
Calcium | 1 kg | 0.25 kg |
1‑Chlorophenyl‑2‑aminopropane | 1 kg | 0.25 kg |
Chromic acid | 0.4 L | 0.1 L |
Chromium trioxide | 0.4 kg | 0.1 kg |
Ephedrine | 1 kg | 0.25 kg |
Ergometrine | 0.0002 kg | 0.00005 kg |
Ergotamine | 0.02 kg | 0.005 kg |
Ethanamine | 2 L | 0.5 L |
Ethyl phenyl acetate | 2 kg | 0.5 kg |
N‑Ethylephedrine | 1 kg | 0.25 kg |
N‑Ethylpseudoephedrine | 1 kg | 0.25 kg |
Eugenol | 0.4 L | 0.1 L |
Formaldehyde | 6 kg | 1.5 kg |
Formamide | 2 L | 0.5 L |
Hydriodic acid | 4 L | 1 L |
Hydrobromic acid | 1 L | 0.25 L |
Hydrogen | 6 kg | 1.5 kg |
Hydrogen chloride | 6 kg | 1.5 kg |
Hydrogen sulfide | 6 kg | 1.5 kg |
4‑Hydroxybutanal | 6 L | 1.5 L |
4-Hydroxybutanoic acid lactone | 2kg | 0.5kg |
4‑Hydroxybutanoic acid nitrile | 6 L | 1.5 L |
4‑Hydroxypentanoic acid | 6 L | 1.5 L |
2‑Hydroxytetrahydrofuran | 6 L | 1.5 L |
Hypophosphite salts | 1 kg | 0.25 kg |
Hypophosphorous acid | 1 L | 0.25 L |
Iodine | 1 kg | 0.25 kg |
Isosafrole | 0.4 L | 0.1 L |
Lithium | 1 kg | 0.25 kg |
Lithium aluminium hydride | 0.2 kg | 0.05 kg |
Lysergic acid | 0.0002 kg | 0.00005 kg |
Magnesium | 1 kg | 0.25 kg |
Mandellic acid | 2 kg | 0.5 kg |
Mercuric chloride | 0.004 kg | 0.001 kg |
Mercury | 0.004 kg | 0.001 kg |
Methcathinone | 1 kg | 0.25kg |
Methylamine | 2 L | 0.5 L |
Methylammonium salts | 1 kg | 0.25 kg |
methyl 3-[3'4'(methylene dioxy)phenyl]-2-methyl glycidate (MMDMG) | 0.4 L | 0.1 L |
3,4‑Methylenedioxyphenylacetic acid | 0.4 kg | 0.1 kg |
3,4‑Methylenedioxyphenylpropan‑2‑one (PMK) | 1L | 0.25L |
N‑Methylformamide | 2 L | 0.5 L |
N‑Methylephedrine | 1 kg | 0.25 kg |
Methyl phenylacetate | 2 kg | 0.5 kg |
N‑Methylpseudoephedrine | 1 kg | 0.25 kg |
Trans β‑Methylstyrene | 2 L | 0.5 L |
Nitroethane | 2 L | 0.5 L |
Nitromethane | 2 L | 0.5 L |
Norpseudoephedrine | 1 kg | 0.25 kg |
Palladium | 0.02 kg | 0.005 kg |
Phenylacetamide | 2 kg | 0.5 kg |
Phenylacetic acid | 2 kg | 0.5 kg |
Phenylacetonitrile | 2 L | 0.5 L |
Phenylacetyl chloride | 2 L | 0.5 L |
Phenylalanine | 2 kg | 0.5 kg |
1‑Phenyl‑2‑bromopropane | 2 kg | 0.5 kg |
1‑Phenyl‑2‑chloropropane | 2 kg | 0.5 kg |
1‑Phenyl‑2‑iodopropane | 2 kg | 0.5 kg |
1‑Phenyl‑2‑nitropropene | 1 kg | 0.25 kg |
Phenylpropanolamine | 2 kg | 0.5 kg |
1‑Phenyl‑2‑propanol | 1 L | 0.25 L |
1‑Phenyl‑1‑Propanone | 1 L | 0.25 L |
1‑Phenyl‑2‑propanone (BMK) | 1 L | 0.25 L |
1‑Phenyl‑2‑propanone oxime | 1 kg | 0.25 kg |
Phosphorus | 0.4 kg | 0.1 kg |
Phosphorous acid | 1 L | 0.25 L |
Piperidine | 0.2 kg | 0.05 kg |
Piperonal | 0.4 kg | 0.1kg |
Platinum | 0.02 kg | 0.005 kg |
Potassium | 1 kg | 0.25 kg |
Propionic anhydride | 0.2 L | 0.05 L |
Pseudoephedrine | 1 kg | 0.25 kg |
Pyridine | 4 L | 1 L |
2-Pyrrolidone | 6 L | 1.5 L |
Raney nickel | 0.2 kg | 0.05 kg |
Safrole | 0.4 L | 0.1 L |
Sassafras oil | 0.4 L | 0.1 L |
Sodium | 1 kg | 0.25 kg |
Sodium bis(2‑methoxyethoxy) aluminium hydride | 0.2 kg | 0.05 kg |
Sodium borohydride | 0.2 kg | 0.05 kg |
Sodium cyanoborohydride | 0.2 kg | 0.05 kg |
Thionyl chloride | 1 kg | 0.25 kg |
Thorium | 4 kg | 1 kg |
Part 1—Controlled plants other than cannabis plants
any
plant of the genus | 800kg | 80kg | 800g |
|
|
| |
|
|
| |
|
|
|
|
|
| |
all
fungi that contain | 10kg | 2.5kg | 1000g |
all
fungi that contain | 10kg | 2.5kg | 1000g |
any plant containing MESCALINE including any plant of the genus Lophophora | |||
5kg | 2.5kg | 250g | |
any
species of the genus | 200kg | 50kg | 10kg |
any
plant of the genus | 100 plants | 20 plants | 10 plants |
(regulation 12)
1 | Offence arising out of the possession of cannabis— | |
| $150 | |
| $300 | |
2 | Offence arising out of the possession of cannabis resin— | |
| $150 | |
| $300 | |
3 | Offence arising out of the smoking or consumption of cannabis or cannabis resin (not being an offence committed in a public place or other prescribed place) | $150 |
4 | Offence arising out of the possession of equipment (1 or more pieces) for use in connection with the smoking or consumption of cannabis or cannabis resin (not being an offence involving the possession of such equipment for commercial purposes) | $150 |
5 | Offence referred to in item 4 accompanied by another simple cannabis offence relating to the possession, smoking or consumption of cannabis or cannabis resin | $30 |
6 | Offence involving cultivation of 1 cannabis plant | $300 |
• Please note—References in the legislation to other legislation or instruments or to titles of bodies or offices are not automatically updated as part of the program for the revision and publication of legislation and therefore may be obsolete.
• Earlier versions of these regulations (historical versions) are listed at the end of the legislative history.
• For further information relating to the Act and subordinate legislation made under the Act see the Index of South Australian Statutes or Substances (Prohibited Substances) Regulations 2000
Controlled Substances (General) Regulations 2000
Revocation of regulations The
Controlled Substances (Controlled Drugs, Precursors and Plants) Regulations 2000 were revoked by Sch 6 cl 1 of theControlled Substances (Controlled Drugs, Precursors and Plants) Regulations 2014 on 4.9.2014.
Legislation revoked by principal regulations The
Controlled Substances (Controlled Drugs, Precursors and Plants) Regulations 2000 revoked the following:
Controlled Substances (Declared Prohibited Substances) Regulations 1985
Principal regulations and variations
Year
No
Reference
Commencement
2000
199
Gazette 31.8.2000 p1002 31.8.2000: r 2
2003
36
Gazette 10.4.2003 p1675 10.4.2003: r 2
2007
264
Gazette 22.11.2007 p4308 3.12.2007: r 2
2008
276
Gazette 16.10.2008 p4870 19.10.2008: r 2
2008
278
Gazette 23.10.2008 p4936 23.10.2008: r 2
2009
213
Gazette 30.7.2009 p3450 4.8.2009: r 2
2009
236
Gazette 10.9.2009 p4426 10.9.2009: r 2
2010
40
Gazette 3.6.2010 p2162 3.6.2010: r 2
2011
141
Gazette 9.6.2011 p2377 1.7.2011: r 2
2011
164
Gazette 23.6.2011 p2716 23.6.2011: r 2
2012
177
Gazette 19.7.2012 p3162 19.7.2012: r 2
2013
233
Gazette 19.9.2013 p3865 19.9.2013: r 2
Provisions varied Entries that relate to provisions that have been deleted appear in italics.
Provision
How varied
Commencement
r 1
varied by 264/2007 r 4
3.12.2007
varied by 141/2011 r 4
1.7.2011
rr 2 and 3
deleted by 264/2007 r 5
3.12.2007 r 4
DDU
inserted by 236/2009 r 4
10.9.2009
midwife
inserted by 213/2009 r 4
4.8.2009
substituted by 40/2010 r 4
3.6.2010
deleted by 233/2013 r 4
19.9.2013
schedule 8
deleted by 264/2007 r 6
3.12.2007 r 4A
inserted by 278/2008 r 4
23.10.2008
r 5
substituted by 264/2007 r 7
3.12.2007
r 6
substituted by 264/2007 r 7
3.12.2007
r 6(1)
varied by 236/2009 r 5(1), (2)
10.9.2009
(b) deleted by 236/2009 r 5(3)
10.9.2009
r 6(2)
varied by 236/2009 r 5(4)
10.9.2009
r 6(2a)
inserted by 236/2009 r 5(5)
10.9.2009
r 6(3)
varied by 236/2009 r 5(6), (7)
10.9.2009
(b) deleted by 236/2009 r 5(8)
10.9.2009
r 6(4)
varied by 236/2009 r 5(9)
10.9.2009
r 6(4a)
inserted by 236/2009 r 5(10)
10.9.2009
r 6(7)
inserted by 236/2009 r 5(11)
10.9.2009
r 6A before deletion by 141/2011
inserted by 213/2009 r 5
4.8.2009
r 6A(1)
varied by 40/2010 r 5
3.6.2010
r 6A
deleted by 141/2011 r 5
1.7.2011 rr 7 and 8
substituted by 264/2007 r 7
3.12.2007
r 8AA
inserted by 276/2008 r 4
19.10.2008
rr 8AB and 8AC
inserted by 236/2009 r 6
10.9.2009
r 8A
inserted by 264/2007 r 7
3.12.2007
r 9
varied by 264/2007 r 8
3.12.2007
varied by 40/2010 r 6
3.6.2010
rr 9A and 9B
inserted by 264/2007 r 9
3.12.2007
r 10
r 10(1)
varied by 278/2008 r 5
23.10.2008
r 11
varied by 264/2007 r 10
3.12.2007
r 13
deleted by 141/2011 r 6
1.7.2011
r 14
inserted by 264/2007 r 11
3.12.2007
(a)(iv) deleted by 236/2009 r 7(1)
10.9.2009
varied by 236/2009 r 7(2)
10.9.2009
deleted by 141/2011 r 6
1.7.2011
rr 15—16
inserted by 264/2007 r 11
3.12.2007
deleted by 141/2011 r 6
1.7.2011 Sch 1
varied by 36/2003 r 4
10.4.2003
substituted by 264/2007 r 12
3.12.2007
varied by 236/2009 r 8(1)—(49)
10.9.2009
varied by 40/2010 r 7(1)—(3)
3.6.2010
Pt 1
substituted by 164/2011 r 4
23.6.2011
varied by 177/2012 r 4(1)—(12)
19.7.2012
varied by 233/2013 r 5(1)—(18)
19.9.2013
Pt 2
varied by 177/2012 r 4(13)
19.7.2012
varied by 233/2013 r 5(19)—(22)
19.9.2013
Sch 2
substituted by 264/2007 r 12
3.12.2007
varied by 236/2009 r 9(1)—(4)
10.9.2009
varied by 164/2011 r 5
23.6.2011
varied by 233/2013 r 6(1), (2)
19.9.2013
Sch 3
substituted by 264/2007 r 12
3.12.2007
varied by 236/2009 r 10
10.9.2009
varied by 233/2013 r 7(1), (2)
19.9.2013
Sch 5
inserted by 264/2007 r 13
3.12.2007
Historical versions
Reprint 1—10.4.2003
3.12.2007
19.10.2008
23.10.2008
4.8.2009
10.9.2009
3.6.2010
23.6.2011
1.7.2011
19.7.2012
0
0
0